ClearAlpha Technologies LP Trims Holdings in HCA Healthcare, Inc. (NYSE:HCA)

ClearAlpha Technologies LP trimmed its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 23.7% during the 3rd quarter, Holdings Channel reports. The firm owned 1,054 shares of the company’s stock after selling 327 shares during the period. ClearAlpha Technologies LP’s holdings in HCA Healthcare were worth $428,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Atria Investments Inc bought a new position in HCA Healthcare in the 1st quarter worth approximately $1,379,000. Cetera Investment Advisers grew its stake in HCA Healthcare by 205.2% during the first quarter. Cetera Investment Advisers now owns 18,753 shares of the company’s stock valued at $6,255,000 after acquiring an additional 12,608 shares in the last quarter. Cetera Advisors LLC lifted its stake in HCA Healthcare by 37.3% in the 1st quarter. Cetera Advisors LLC now owns 7,049 shares of the company’s stock worth $2,351,000 after purchasing an additional 1,916 shares in the last quarter. GAMMA Investing LLC grew its position in shares of HCA Healthcare by 18.8% during the second quarter. GAMMA Investing LLC now owns 1,290 shares of the company’s stock valued at $414,000 after purchasing an additional 204 shares in the last quarter. Finally, Massmutual Trust Co. FSB ADV lifted its position in shares of HCA Healthcare by 40.5% in the second quarter. Massmutual Trust Co. FSB ADV now owns 392 shares of the company’s stock worth $126,000 after buying an additional 113 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

A number of research firms have issued reports on HCA. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 price objective on shares of HCA Healthcare in a research note on Tuesday, October 1st. Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, August 29th. TD Cowen decreased their target price on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Barclays reduced their price objective on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a research note on Friday, November 8th. Finally, Truist Financial lifted their target price on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $380.29.

Insider Activity

In other news, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the sale, the senior vice president now directly owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This represents a 21.97 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 15,155 shares of company stock worth $5,608,990. Corporate insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $327.22 on Monday. The firm has a market cap of $82.88 billion, a PE ratio of 14.69, a price-to-earnings-growth ratio of 1.26 and a beta of 1.68. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. HCA Healthcare, Inc. has a one year low of $246.60 and a one year high of $417.14. The firm’s 50 day simple moving average is $371.88 and its 200-day simple moving average is $358.84.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be paid a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.81%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.